NCT00131326已完成3 期
A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the Hip
Genzyme, a Sanofi Company63 个研究点 分布在 1 个国家开始时间: 2003年11月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 63
- 主要终点
- Pain relief
研究概览
简要总结
This is a clinical study to investigate the safety and efficacy of Synvisc and Depo-Medrol in treating patients with osteoarthritis (OA) of the hip.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 35 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with symptomatic osteoarthritis pain of hip
排除标准
- •Patients with current or prior conditions or treatment that would impede measurement of efficacy and safety
结局指标
主要结局
Pain relief
次要结局
未报告次要终点
研究者
研究点 (63)
Loading locations...
相似试验
已完成
3 期
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder OsteoarthritisMusculoskeletal DiseasesOsteoarthritisNCT00131300Genzyme, a Sanofi Company
已完成
3 期
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle OsteoarthritisOsteoarthritisNCT00131768Genzyme, a Sanofi Company
已完成
2 期
Simvastatin Plus Rifaximin in Decompensated CirrhosisCirrhoses, LiverNCT03150459Judit Pich44
招募中
1 期
To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy AdultsDyslipidemiasType 2 DiabetesNCT06578676Hyundai Pharm56
招募中
3 期
Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AMLAcute Myeloid LeukemiaNCT05264883The First Affiliated Hospital with Nanjing Medical University170